J.J. Jager

5.9k citations

51 papers · 3.8k indexed · 3 hit papers · h-index 23

Impact in

Cancer Research top 0.5%
- Breast Cancer Treatment Studies
Radiation top 0.5%
- Advanced Radiotherapy Techniques

Papers in

Cancer Research 32
- Breast Cancer Treatment Studies 30
- Cancer Genomics and Diagnostics 4
Radiation 8
- Advanced Radiotherapy Techniques 8

Co-authors: M. Piérart Harry Bartelink H. Struikmans Alain Fourquet Laurence Collette W.J. Hoogenraad Philip Poortmans Jean-Claude Horiot
Journals: Radiotherapy and Oncology (10 papers)European Journal of Cancer (9 papers)International Journal of Radiation Oncology*Biology*Physics (7 papers)Annals of Oncology (2 papers)Journal of Clinical Oncology (2 papers)
Partner nations: Netherlands France Belgium

In The Last Decade

J.J. Jager

49 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial 2007 · 722 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Journal of Clinical Oncology
2001 New England Journal of Medicine
1996 International Journal of Radiation Oncology*Biology*Physics

Peers

Countries citing papers authored by J.J. Jager

Since Specialization

Citations

This map shows the geographic impact of J.J. Jager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Jager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Jager more than expected).

Fields of papers citing papers by J.J. Jager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Jager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Jager. The network helps show where J.J. Jager may publish in the future.

Co-authorship network

The 25 scholars most cited alongside J.J. Jager, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.J. Jager Line = papers co-authored together J.J. Jager links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pancreatic adenocarcinoma patients with pain have abnormal central pain processing Pancreatology ·Mahya Faghih, علي صاحب عباس, Tomás Arias, J.J. Jager, Søren Schou Olesen, Daniel A. Laheru, Lei Zheng, Anna E. Phillips, Dhiraj Yadav, Asbjørn Mohr Drewes, Jonas Rosendahl, Vikesh K. Singh	2025	0
2	Set-up verification and 2-dimensional electronic portal imaging device dosimetry during breath hold compared with free breathing in breast cancer radiation therapy Practical Radiation Oncology ·Selma F. Knijnik, Tim Lustberg, Jacques Borger, W. R. Cho, J.J. Jager, L. Murrer, Hosny Abd-El-Dayem, Yerru Bhavitha, R.R. Lee, Liesbeth Boersma	2014	17
3	Is contrast enhancement required to visualize a known breast tumor in a pre-operative CT scan? Radiotherapy and Oncology ·Liesbeth Boersma, 刘九皋, C. Boetes, Jacques Borger, Piet van den Ende, 信亲林, Ruud Houben, J.J. Jager, L. Murrer, S H Sastrowijoto, Angela van Baardwijk	2011	3
4	Customized Computed Tomography-Based Boost Volumes in Breast-Conserving Therapy: Use of Three-Dimensional Histologic Information for Clinical Target Volume Margins International Journal of Radiation OncologyBiologyPhysics ·刘九皋, Jacques Borger, Piet van den Ende, 曾昭贤, Ruud Houben, J.J. Jager, Kristien Keymeulen, L. Murrer, S H Sastrowijoto, Koen Van de Vijver, Liesbeth Boersma	2009	20
5	Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’ European Journal of Cancer ·Sandra Collette, Laurence Collette, Tom Budiharto, Jean-Claude Horiot, Philip Poortmans, H. Struikmans, Walter Van den Bogaert, Alain Fourquet, J.J. Jager, W.J. Hoogenraad, Rolf‐Peter Mueller, John M. Kurtz, D.A.L. Morgan, Jean‐Bernard Dubois, E. Salamon, R.O. Mirimanoff, M. Bolla, Francisco José Armenteros Ruiz, Carla C. Wárlám-Rodenhuis, Harry Bartelink	2008	157
6	The Impact of Boost Dose and Margins on the Local Recurrence Rate in Breast Conserving Therapy: Results From the EORTC Boost-No Boost Trial International Journal of Radiation OncologyBiologyPhysics ·Helen Jones, Ninja Antonini, Bonnie L. MacDougall, Alain Fourquet, W.J. Hoogenraad, W. Van den Bogaert, J.J. Jager, P. Poortmans, H. Struikmans, Harry Bartelink	2007	6
7	Prone breast irradiation for pendulous breasts Radiotherapy and Oncology ·Jeroen Buijsen, J.J. Jager, Alfredo Canellas Guilherme da Silva, F Tuijman, Jacques Borger, Liesbeth Boersma, L. Murrer, Philippe Lambin	2006	46
8	Radiation-induced bullous pemphigoid: A systematic review of an unusual radiation side effect Radiotherapy and Oncology ·Véronique E. Mul, Adrienne J. van Geest, Madelon Pijls-Johannesma, Jan Theys, Tom Verschueren, J.J. Jager, Philippe Lambin, Brigitta G. Baumert	2006	45
9	Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? European Journal of Cancer ·Conny Vrieling, Laurence Collette, Alain Fourquet, W.J. Hoogenraad, Jean-Claude Horiot, J.J. Jager, S.B. Oei, Hans Peterse, M. Piérart, P. Poortmans, H. Struikmans, W. Van den Bogaert, Harry Bartelink	2003	130
10	Clinical relevance of apoptotic markers in breast cancer not yet clear APOPTOSIS ·J.J. Jager, Rob L. H. Jansen, Jan Willem Arends	2002	12
11	Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) for node-positive cancer patients, update at 12 years follow up The Breast ·P. Hupperets, Jaeho Jung, Lex Volovics, Leo J. Schouten, M. Fickers, 英昭稲森, J.J. Jager, J.M.A. de Jong, G.H. Blijham	2001	10
12	Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation New England Journal of Medicine ·Harry Bartelink, Jean-Claude Horiot, Philip Poortmans, H. Struikmans, Walter Van den Bogaert, I. Barillot, Alain Fourquet, Jacques Borger, J.J. Jager, W.J. Hoogenraad, Laurence Collette, M. Piérart Hit paper breakdown →	2001	693
13	The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC ‘boost vs. no boost’ trial Radiotherapy and Oncology ·Conny Vrieling, Laurence Collette, Alain Fourquet, W.J. Hoogenraad, J.C. Horiot, J.J. Jager, M. Piérart, Philip Poortmans, H. Struikmans, B. Maat, Erik Van Limbergen, Harry Bartelink	2000	250
14	Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation Radiotherapy and Oncology ·J.J. Jager, Lex Volovics, Leo J. Schouten, J.M.A. de Jong, P. Hupperets, M.F. von Meyenfeldt, Bert Schutte, Geert H. Blijham	1999	32
15	The Prognostic Significance of Steroid Receptor Activity in Tumor Tissues of Patients with Primary Breast Cancer American Journal of Clinical Oncology ·P. Hupperets, Lex Volovics, Leo J. Schouten, J.J. Jager, Harry C. Schouten, H.F.P. Hillen, Geert H. Blijham	1997	20
16	Validity of the stage of lung cancer in records of the Maastricht cancer registry, The Netherlands Lung Cancer ·Leo J. Schouten, Johannes A. Langendijk, J.J. Jager, Piet A. van den Brandt	1997	10
17	Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, the Netherlands Annals of Oncology ·J.M. de Rijke, Leo J. Schouten, Harry C. Schouten, J.J. Jager, Laercio Amoras, Piet A. van den Brandt	1996	103
18	A single session of intraluminal brachytherapy in palliation of oesophageal cancer Radiotherapy and Oncology ·J.J. Jager, Johannes A. Langendijk, Bryant C. Pedigo, Joop Rijken, Jos de Jong	1995	37
19	Patient population analysis in eortc trial 22881/10882 on the role of a booster dose in breast-conserving therapy European Journal of Cancer ·Daniela Juarez, W. Van den Bogaert, M. van Glabbeke, M. Piérart, Harry Bartelink, Jean-Claude Horiot, Alain Fourquet, H. Struikmans, Han Hamers, R.-P. Müller, W.J. Hoogenraad, J.J. Jager, Emmanuel van der Schueren	1994	22
20	Cancer incidence in the province of Limburg, The Netherlands European Journal of Cancer ·Leo J. Schouten, Piet A. van den Brandt, J.J. Jager	1992	8

About J.J. Jager

J.J. Jager is a scholar working on Cancer Research, Radiation, Oncology, Pathology and Forensic Medicine and Otorhinolaryngology, having authored 51 papers that have together received 3.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (30 papers), Breast Lesions and Carcinomas (12 papers), Advanced Radiotherapy Techniques (8 papers), Cancer Risks and Factors (4 papers), Cancer Genomics and Diagnostics (4 papers), Breast Implant and Reconstruction (4 papers), Global Cancer Incidence and Screening (4 papers) and Medical Imaging Techniques and Applications (3 papers). The work is most often cited by research in Cancer Research (2.5k citations), Radiation (962 citations), Pathology and Forensic Medicine (1.4k citations), Genetics (501 citations) and Oncology (1.1k citations). J.J. Jager has collaborated with scholars based in Netherlands, France and Belgium. Frequent co-authors include M. Piérart, Harry Bartelink, H. Struikmans, Alain Fourquet, Laurence Collette, W.J. Hoogenraad, Philip Poortmans, Jean-Claude Horiot, Walter Van den Bogaert and Carla C. Wárlám-Rodenhuis. Their work appears in journals such as Radiotherapy and Oncology, European Journal of Cancer, International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact